|
DRUG Bright Minds Biosciences Inc 1827401 |
| Income Statement |
|
Net Income
|
2024-09-30
|
$-2,801,946.00 |
| Balance Sheet |
|
Current Assets
|
$5,986,944.00 |
|
Assets
|
$6,104,602.00 |
|
Current Liabilities
|
$528,683.00 |
|
Liabilities
|
$568,259.00 |
|
Equity
|
$5,536,343.00 |
|
Shares Out
|
4524087.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,850,186.00 |
| Market Analysis |
Market Cap
|
$355,412,274.72 |
|
Price
|
$78.56 |
|
BVPS
|
1.22 |
|
PB
|
64.39 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-19 |
-0.79 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DRUG documents filed with the SEC.
DRUG Filings
Clear
